Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Submitted by
admin
on September 18, 2013 - 8:48am
Source:
Yahoo/Reuters
News Tags:
China
GSK
Headline:
Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Do Not Allow Advertisers to Use My Personal information
